{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-004572","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2024-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.921129+00:00","generated_at":"2026-05-31T23:58:02.693523+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Sunshine Biopharma gets Nasdaq bid-price extension to Aug 26, 2024","bullets":["Received Nasdaq Hearings Panel exception until August 26, 2024 to regain minimum bid price compliance.","Must achieve closing bid price of at least $1.00 for 10 consecutive business days by deadline.","Company was previously notified of deficiency under Listing Rule 5550(a)(2).","Failure to meet conditions may result in delisting from Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-004572","json":"https://secwatch.observer/filing/0001683168-24-004572.json","markdown":"https://secwatch.observer/filing/0001683168-24-004572.md","text":"https://secwatch.observer/filing/0001683168-24-004572.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316824004572/0001683168-24-004572-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316824004572/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:58:02.693523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}